Caplin Point Laboratories will release figures for the most recent quarter on August 12. Analysts expect earnings per share of INR 6.72. Go here to track Caplin Point Laboratories stock price in ...

Track Caplin Point Laboratories share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and ...

Earnings call Caplin Point Laboratories reported a 10.6% YoY revenue growth and 20.5% PAT increase in Q3 FY26, with EBITDA margin expanding to 38.5%. Management reaffirmed a consolidation phase ...

Caplin Point Laboratories releases figures for Q4 on May 22. Analysts expect Caplin Point Laboratories will report earnings per share of INR 6.28. Track Caplin Point Laboratories stock price in ...

Caplin Point Laboratories Share Price | The company's subsidiary received final approval for for Methylprednisolone Acetate injection from the USFDA. Caplin Point Laboratories shares gained 2 percent ...

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The goal of this article is to teach you how to use price to earnings ratios ...

Get all latest & breaking news on Caplin Point Laboratories. Watch videos, top stories and articles on Caplin Point Laboratories at moneycontrol.com.

Shares of Caplin Point Laboratories ended on a flat note on Tuesday even as the firm said Caplin Steriles Limited (Caplin), a subsidiary of Caplin Point Laboratories Limited has received final ...

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have ...

This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about the link between company’s fundamentals and stock market performance.

Earnings call Caplin Point reported a solid Q1 FY25 with 17% YoY revenue growth and 20% YoY PAT growth, supported by rising gross margins (up to 58.6%) and strong U.S. business momentum. Management ...